Caplan, Arthur L.
Email Address
ORCID
Disciplines
Search Results
Now showing 1 - 10 of 31
Publication Successes and Failures of Hospital Ethics Committees: A National Survey of Ethics Committee Chairs(2002-01-01) McGee, Glenn E; Caplan, Arthur L.; Spanogle, Joshua P; Asch, David A.; Penny, DinaIn 1992, the Joint Commission on the Accreditation of Healthcare Organizations (JCAHO) passed a mandate that all its approved hospitals put in place a means for addressing ethical concerns. Although the particular process the hospital uses to address such concerns—ethics consultant, ethics forum, ethics committee—may vary, the hospital or healthcare ethics committee (HEC) is used most often. In a companion study to that reported here, we found that in 1998 over 90% of U.S. hospitals had ethics committees, compared to just 1% in 1983, and that many have some and a few have sweeping clinical powers in hospitals.Publication Bioethics Consultation in the Private Sector(2002-06-01) Brody, Baruch; Dubbler, Nancy; Caplan, Arthur L.; Blustein, Jeff; Kahn, Jeffrey P; Kass, Nancy; Moreno, Jonathan; Lo, Bernard; Sugarman, Jeremy; Zoloth, LaurieThe members of a task force on bioethics consultation report their conclusions. The task force was convened by the American Society for Bioethics and Humanities and the American Society of Law, Medicine, and Ethics, although these groups do not endorse the group's conclusions. Two commentaries follow, and an essay by science reporter Nell Boyce sets the scene.Publication "Who Lost China?" A Foreshadowing of Today's Ideological Disputes in Bioethics(2005-06-01) Caplan, Arthur L.Throughout the early 1950s, as the Korean War raged, a single contentious question consumed political debate in the United States: Who lost China? Political opponents tossed this question back and forth hoping that the tar baby would stick to someone on the other side and let them affix blame both for the Korean War and, more importantly, for allowing communists to seize control of the most populous nation on earth.Publication All Gifts Large and Small(2003-07-01) Caplan, Arthur L.; Katz, Dana; Merz, Jon FMuch attention has been focused in recent years on the ethical acceptability of physicians receiving gifts from drug companies. Professional guidelines recognize industry gifts as a conflict of interest and establish thresholds prohibiting the exchange of large gifts while expressly allowing for the exchange of small gifts such as pens, note pads, and coffee. Considerable evidence from the social sciences suggests that gifts of negligible value can influence the behavior of the recipient in ways the recipient does not always realize. Policies and guidelines that rely on arbitrary value limits for gift-giving or receipt should be reevaluated.Publication Is it ethical to use enhancement technologies to make us better than well?(2004-12-01) Caplan, Arthur L.; Elliot, CarlBackground to the debate: A variety of biomedical technologies are being developed that can be used for purposes other than treating disease. Such "enhancement technologies" can be used to improve our appearance and regulate our emotions, with the goal of feeling "better than well." While these technologies can help people adapt to their rapidly changing lifestyles, their use raises important ethical issues.Publication Right to reform(2009-09-10) Caplan, Arthur LHealth reform is not in the details. Think I am wrong? How far did we get this summer wallowing around in claims about co-ops, public plans, death panels, rationing, and cost savings? Health reform is in the ethics.Publication Special Supplement: Ethical and Policy Issues in Rehabilitation Medicine(1987-08-01) Caplan, Arthur L.; Callahan, Daniel; Haas, JanetThe field of medical rehabilitation is relatively new, a product in great part of the rapid developments in medical science during and after the Second World War. Until recently, the ethical problems of this new field were neglected. There seemed to be more pressing concerns as rehabilitation medicine struggled to establish itself, somtimes in the face of considerable skepticism or hostility. There also seemed no pressing moral questions of the kind and intensity to be encountered, say, in high technology acute care medicine or genetic engineering. With eyes focused on the dramatic and wrenching problems, those in biomedical ethics could and did easily overlook the quiet, less obtrusive, issues of rehabilitation.Publication Does the biomedical revolution spell the end of sport?(2008-09-18) Caplan, Arthur LPublication Straining Their Brains: Why the Case Against Enhancement is Not Persuasive.(2004-09-01) Caplan, Arthur L.; McHugh, Paul RYour kid’s schoolwork not up to par? Looking for Mr. or Ms. Right? Any other problems caused by a mind’s eye seemingly not quite on the ball? Answers might lie in a brain-enhancing pill. Some argue this is merely better living through chemistry and in line with humanity’s self-improving actions throughout history, but others suggest that quick-fix medications could well distort the very things that make us human. Here a leading bioethicist squares off with a member of the President’s Council on Bioethics on the controversy about pursuing better brains with a little help from biotechnology.Publication Organ Transplants: The Cost of Success(1983-12-01) Caplan, Arthur L.Just thirty years after the first kidney transplant between identical twins was undertaken in 1954, organ transplantation has come of age. Today many transplant surgeons have attained success rates of over 80 percent survival for at least five years among those who have received kidneys from live related donors. The survival rate for those who receive cadaver kidneys five years after surgery is 60 percent. More than 95 percent of corneal transplant recipients have their sight restored.